Post-genomic Approaches in Drug and Vaccine Development

Over the past decade genome sequencing projects and the associated efforts have facilitated the discovery of several novel disease targets and the approval of several innovative drugs. To further exploit this data for human health and disease there is a need to understand the genome data itself in detail discover novel targets understand their role in physiological pathways and associated diseases with the aim to translate these discoveries to clinical and preventive medicine. It is equally important to understand the labors and limitations in integrating clinical phenotypes with genomic transcriptomic proteomic and metabolomic approaches. T